NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.74% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.66% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.64% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.63% |
UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.63% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.58% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.57% |
INCY | Incyte Corporation | Healthcare | Biotechnology | 1.57% |
SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.57% |
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.56% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.55% |
INSM | Insmed Inc | Healthcare | Biotechnology | 1.55% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.54% |
EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.52% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.50% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 1.50% |
KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.41% |
VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 1.39% |
TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.30% |